pharma news today obesity drugs glp-1 today What is the pipeline for future medications for obesity? GLP-1 Antagonists Increase Plan Drug
Description
Products to support your goals Find products* you may need along your journey, from snacks and supplements to hydration, digestive support and more
However, a significant effect on major kidney outcomes was not observed (HR 0.91, 95% CI 0.801.05)
Hagstrom, J
Disadvantages, compared to sitagliptin, include an injectable dosage form and gastrointestinal side effects
Nat Med 8, 738742 (2002)
